Bioextrax AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was SEK 0.12 million. Revenue was SEK 0.502374 million compared to SEK 0.026284 million a year ago. Net loss was SEK 5.56 million compared to SEK 3.04 million a year ago. Basic loss per share from continuing operations was SEK 0.3661 compared to SEK 0.2062 a year ago.
For the six months, sales was SEK 0.242474 million compared to SEK 0.04 million a year ago. Revenue was SEK 0.917016 million compared to SEK 0.066284 million a year ago. Net loss was SEK 8.27 million compared to SEK 5.07 million a year ago. Basic loss per share from continuing operations was SEK 0.5449 compared to SEK 0.3437 a year ago.